Arijit Sil

Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study

María Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse et al. · EClinicalMedicine · 2020 · 23 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report

María Rosario Capeding, Edison Alberto, Arijit Sil et al. · Vaccine · 2019 · 22 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +17

One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine

Bernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi et al. · International Journal of Infectious Diseases · 2020 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

Bernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi et al. · BMC Pediatrics · 2020 · 16 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants

Dulari J. Gandhi, Sangappa Dhaded, Mandyam Dhati Ravi et al. · Human Vaccines & Immunotherapeutics · 2015 · 12 citations · Full text

Veterinary Medicine, Child Health, Pediatrics +17